{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2026-01-26T12:28:35.616667+00:00",
  "news": [
    {
      "title": "A Look At Vertex Pharmaceuticals (VRTX) Valuation After Recent Analyst Upgrades And CASGEVY Approval - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMikgFBVV95cUxOaWFXd2FTNmg2b01naEt4SzUyckdCbHl6a2JmZXFUS3pTUDdheVhKYzUxRnhQR0NiNlZCY0ZOSlR1TVBYRXlMdXNpR0VzWmRSYVJDd2NzTTVtcUtWdXFyb0lqdmRTNnVXUTBBX1g2UVJSVEhoekxsaWpjTjNJMjhQWkM1S2g3TDE4Vmh0SUNtRURuQQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikgFBVV95cUxOaWFXd2FTNmg2b01naEt4SzUyckdCbHl6a2JmZXFUS3pTUDdheVhKYzUxRnhQR0NiNlZCY0ZOSlR1TVBYRXlMdXNpR0VzWmRSYVJDd2NzTTVtcUtWdXFyb0lqdmRTNnVXUTBBX1g2UVJSVEhoekxsaWpjTjNJMjhQWkM1S2g3TDE4Vmh0SUNtRURuQQ?oc=5\" target=\"_blank\">A Look At Vertex Pharmaceuticals (VRTX) Valuation After Recent Analyst Upgrades And CASGEVY Approval</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2026-01-25T02:08:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "RBC Capital Upgrades Vertex Pharmaceuticals (VRTX) - Nasdaq",
      "link": "https://news.google.com/rss/articles/CBMihwFBVV95cUxPM1NESC1OalIxRDF6WmMxVldPaGVRQ3FPRk9USmc5MkdvTGNwdHNDVnZ5cXhvcEhsVDdJYXpKZEk5MzNGbGF4bW5Yb2p2cTBWdnpzV0JCVjRVQjBYMGZIVGREZmRVSUlDeER1dEVMaTA0ekdOZkxVX3dlVjloZlF4TWJJSUhZLVU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihwFBVV95cUxPM1NESC1OalIxRDF6WmMxVldPaGVRQ3FPRk9USmc5MkdvTGNwdHNDVnZ5cXhvcEhsVDdJYXpKZEk5MzNGbGF4bW5Yb2p2cTBWdnpzV0JCVjRVQjBYMGZIVGREZmRVSUlDeER1dEVMaTA0ekdOZkxVX3dlVjloZlF4TWJJSUhZLVU?oc=5\" target=\"_blank\">RBC Capital Upgrades Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Nasdaq</font>",
      "published": "2026-01-23T00:02:00+00:00",
      "source": "Nasdaq"
    },
    {
      "title": "Responsibility | Grants and Giving - Vertex Pharmaceuticals",
      "link": "https://news.google.com/rss/articles/CBMikAFBVV95cUxPempkZnJfemR2dHhGT3ZsRkJ0UDdUZ0pUUURUczhJS0I3N1JMVS04YmpRNGF0UXA2dmxFVF9seXZXRlFBUW5ZUmNZX0pGNHQ4VGFIMFFvSFhNX3VaUHA1Rm44T2pLbUctMDV6LWdXeHlzaWV4cHRIXzlvSjVwM3VkaVdxTnZKemluVC1KZUhrUHQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikAFBVV95cUxPempkZnJfemR2dHhGT3ZsRkJ0UDdUZ0pUUURUczhJS0I3N1JMVS04YmpRNGF0UXA2dmxFVF9seXZXRlFBUW5ZUmNZX0pGNHQ4VGFIMFFvSFhNX3VaUHA1Rm44T2pLbUctMDV6LWdXeHlzaWV4cHRIXzlvSjVwM3VkaVdxTnZKemluVC1KZUhrUHQ?oc=5\" target=\"_blank\">Responsibility | Grants and Giving</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Vertex Pharmaceuticals</font>",
      "published": "2026-01-21T19:40:49+00:00",
      "source": "Vertex Pharmaceuticals"
    },
    {
      "title": "Y Intercept Hong Kong Ltd Takes $10.88 Million Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMi7wFBVV95cUxPXzgzTHdyeVlnaHNHTXA3bjZERWJfQXNvR2lLamFLLUtmdy1JdnlON2x6N3phZ0FOdmhaS2JIQzhLVnVJVEE2N3RwRENjc3lQTmw1bkZzdGlzeFJ0ZHVGRHRwcGVGVDBHRC1fSE5zWHRpTnlpM1NLTjlOcmkzdWFsbEV2aVBZQmNYTnhITWt6cmkyeVh6MXBXTUszb1cyLWdWVDV6ZlRjYzlUdDJFQ1p0alhnbDd5SE1XTTVyeWZnaXVSd3Z6TF85dDV5eHVpWk80UTNSUEd5UndqbGNZckZjSjJyakZuc3FTOUFteVdzYw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi7wFBVV95cUxPXzgzTHdyeVlnaHNHTXA3bjZERWJfQXNvR2lLamFLLUtmdy1JdnlON2x6N3phZ0FOdmhaS2JIQzhLVnVJVEE2N3RwRENjc3lQTmw1bkZzdGlzeFJ0ZHVGRHRwcGVGVDBHRC1fSE5zWHRpTnlpM1NLTjlOcmkzdWFsbEV2aVBZQmNYTnhITWt6cmkyeVh6MXBXTUszb1cyLWdWVDV6ZlRjYzlUdDJFQ1p0alhnbDd5SE1XTTVyeWZnaXVSd3Z6TF85dDV5eHVpWk80UTNSUEd5UndqbGNZckZjSjJyakZuc3FTOUFteVdzYw?oc=5\" target=\"_blank\">Y Intercept Hong Kong Ltd Takes $10.88 Million Position in Vertex Pharmaceuticals Incorporated $VRTX</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2026-01-24T14:15:46+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "Vertex Pharma upgraded at RBC Capital Markets citing upside in 2026 - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMihwFBVV95cUxQMXAxdXFBdll1SURrdG52a1V1cXVDa281c09zRkFxOFRxYkVqSHhWVDI0ZlFtRHVMNmdrNWZON01zZ1BLeFdQMHVzT2ktSmhhZkdqbXVHcmxWeDhGMkV4WnlQbGg1OFVWc0p0ZC02Q2NqSHZpMzAxLU5HNGxWUjQyWWxjMEljZ2c?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihwFBVV95cUxQMXAxdXFBdll1SURrdG52a1V1cXVDa281c09zRkFxOFRxYkVqSHhWVDI0ZlFtRHVMNmdrNWZON01zZ1BLeFdQMHVzT2ktSmhhZkdqbXVHcmxWeDhGMkV4WnlQbGg1OFVWc0p0ZC02Q2NqSHZpMzAxLU5HNGxWUjQyWWxjMEljZ2c?oc=5\" target=\"_blank\">Vertex Pharma upgraded at RBC Capital Markets citing upside in 2026</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2026-01-22T15:59:44+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "Breaking Down Vertex Pharmaceuticals: 12 Analysts Share Their Views - Benzinga",
      "link": "https://news.google.com/rss/articles/CBMiywFBVV95cUxNOTBPUERHS2g4emhZcVdtWjFBQmUzRE9ERURDdHZWQTlYSEQtQktXMVMzRVNqNGwxWE5BeGJBdWttU1lYOG1JTWxMSEdfZlctYXBYMTVhS1FfNUhwX3NyQTRQVDBBYzRaYm5uMUFBaFVmcVIxaVJQNEUxVS1oZW96QndaWTF3Y0NJVU55aTROWEtkcHBNNjkwWDFzajRxSndJb1NnZWY1TmVJNzRNOHZxRWRBY1VhVjI1WDJFdzdYS19vLTdmWWR4T3FBaw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiywFBVV95cUxNOTBPUERHS2g4emhZcVdtWjFBQmUzRE9ERURDdHZWQTlYSEQtQktXMVMzRVNqNGwxWE5BeGJBdWttU1lYOG1JTWxMSEdfZlctYXBYMTVhS1FfNUhwX3NyQTRQVDBBYzRaYm5uMUFBaFVmcVIxaVJQNEUxVS1oZW96QndaWTF3Y0NJVU55aTROWEtkcHBNNjkwWDFzajRxSndJb1NnZWY1TmVJNzRNOHZxRWRBY1VhVjI1WDJFdzdYS19vLTdmWWR4T3FBaw?oc=5\" target=\"_blank\">Breaking Down Vertex Pharmaceuticals: 12 Analysts Share Their Views</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Benzinga</font>",
      "published": "2026-01-23T19:01:03+00:00",
      "source": "Benzinga"
    },
    {
      "title": "Vertex CASGEVY Approval Adds Gene Editing Pillar To Growth Story - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">Vertex CASGEVY Approval Adds Gene Editing Pillar To Growth Story</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2026-01-24T10:00:48+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "Does Vertex Pharmaceuticals (VRTX) Share Price Reflect Its Long Term Growth Potential? - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijAFBVV95cUxPWDRSd0xMTFdtYWxxNlRxUkRpMzNTTndHNlVRSFdZN0FhakJ4dFZVNk9zenQ4MW5UZzkySHVESTR5RFpyVFZBRjZ6SnpfQm94SjdTby1jaVo1LUFFczFuS3M1dU5ua240NEdLR0hvX3Zhd1VJa19rTE5uSGJiYTRDLTJWNWtkV3NsMV9qag?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijAFBVV95cUxPWDRSd0xMTFdtYWxxNlRxUkRpMzNTTndHNlVRSFdZN0FhakJ4dFZVNk9zenQ4MW5UZzkySHVESTR5RFpyVFZBRjZ6SnpfQm94SjdTby1jaVo1LUFFczFuS3M1dU5ua240NEdLR0hvX3Zhd1VJa19rTE5uSGJiYTRDLTJWNWtkV3NsMV9qag?oc=5\" target=\"_blank\">Does Vertex Pharmaceuticals (VRTX) Share Price Reflect Its Long Term Growth Potential?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2026-01-09T08:00:00+00:00",
      "source": "Yahoo Finance"
    }
  ],
  "product_launches": [
    {
      "title": "Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX) - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5\" target=\"_blank\">Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-22T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex’s new pain, blood disorder drugs miss Wall Street expectations - BioPharma Dive",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5\" target=\"_blank\">Vertex’s new pain, blood disorder drugs miss Wall Street expectations</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioPharma Dive</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "BioPharma Dive"
    },
    {
      "title": "Vertex’s New Products Dim as Analysts Eye Kidney Portfolio - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMilgFBVV95cUxObHk5T3lvemFXaFY4LXUwYkNCRHBBNk1KQ1gwVFZ5Wmw2RW4xTEpWcXFoZ3YtaXJUUWd3c0Z3U0xnSkU3Q0VHUkhqVjh1cTJKME9FY0kzSDRGN2pIaWh5MDlyUVU3OHY0WEFCRHpnaXdEUkFZTWRxeWdvQWU1MVBBZ0FNRXZKLU45RUFQb2F2UmRjTmw2UGc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilgFBVV95cUxObHk5T3lvemFXaFY4LXUwYkNCRHBBNk1KQ1gwVFZ5Wmw2RW4xTEpWcXFoZ3YtaXJUUWd3c0Z3U0xnSkU3Q0VHUkhqVjh1cTJKME9FY0kzSDRGN2pIaWh5MDlyUVU3OHY0WEFCRHpnaXdEUkFZTWRxeWdvQWU1MVBBZ0FNRXZKLU45RUFQb2F2UmRjTmw2UGc?oc=5\" target=\"_blank\">Vertex’s New Products Dim as Analysts Eye Kidney Portfolio</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results - TIKR.com",
      "link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TIKR.com</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "TIKR.com"
    },
    {
      "title": "Vertex, with new launches gaining steam, boosts revenue forecast despite Trikafta dilemma in Russia - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOZ0RxdG8zMm1DUDBpWlFZdk1fMlZBOTlnZi03RTBQYVlKSWRQQ3hNOEhQMUoxVXJRelFTX3RyNkk5X3RwV0IyODkwSVNXR0NHTWVpTHhBRXpvSDAxemJQTjRvWjY2aUpQMXpiNExLRXZ1dkdpY1dudE5FWm10Y1lKVzg3dHcyd2FkZ0RvdlJqSmVJTFFlRS1rbm10aWh2M2lpMnpoVWRWZXVRM1JYeXAxbm9TQ1ZhMWozMWZXY2I1REkwSlE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwwFBVV95cUxOZ0RxdG8zMm1DUDBpWlFZdk1fMlZBOTlnZi03RTBQYVlKSWRQQ3hNOEhQMUoxVXJRelFTX3RyNkk5X3RwV0IyODkwSVNXR0NHTWVpTHhBRXpvSDAxemJQTjRvWjY2aUpQMXpiNExLRXZ1dkdpY1dudE5FWm10Y1lKVzg3dHcyd2FkZ0RvdlJqSmVJTFFlRS1rbm10aWh2M2lpMnpoVWRWZXVRM1JYeXAxbm9TQ1ZhMWozMWZXY2I1REkwSlE?oc=5\" target=\"_blank\">Vertex, with new launches gaining steam, boosts revenue forecast despite Trikafta dilemma in Russia</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-05-06T07:00:00+00:00",
      "source": "Fierce Pharma"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2026-01-23",
      "close": 468.4100036621094
    },
    "history": [
      {
        "date": "2026-01-14",
        "close": 449.5299987792969
      },
      {
        "date": "2026-01-15",
        "close": 438.9200134277344
      },
      {
        "date": "2026-01-16",
        "close": 441.3599853515625
      },
      {
        "date": "2026-01-20",
        "close": 442.0799865722656
      },
      {
        "date": "2026-01-21",
        "close": 461.1400146484375
      },
      {
        "date": "2026-01-22",
        "close": 467.3500061035156
      },
      {
        "date": "2026-01-23",
        "close": 468.4100036621094
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}